混合抗微生物的In silico设计和评估,用于对抗环境中多种耐药细菌
Heyang Huang1, Lina Sheng1, Yongli Ye1
1School of Food Science and Technology, International Joint Laboratory on Food Safety, Synergetic Innovation Center of Food Safety and Quality Control, Jiangnan University, Wuxi, Jiangsu 214122, PR China; Key Laboratory of Screening, Prevention, and Control of Food Safety Risks, State Administration for Market Regulation, Wuxi, Jiangsu 214122, PR China; Institute of Future Food Technology, JITRl, Yixing 214200, PR China.
Journal of hazardous materials
|February 28, 2026
概括
研究人员开发了一种新方法来制造抗微生物 (AMP),有效对抗耐药细菌. 这种由人工智能驱动的方法加速了针对具有挑战性的感染的新治疗方法的发现.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 细菌的多药性耐药性 (MDR) 构成了全球健康的重大威胁.
- 传统的抗微生物 (AMP) 在结构稳定性和有效发现方面面临局限性.
- 对于开发有效的抗微生物剂的新策略有着至关重要的需求.
研究的目的:
- 设计和识别新型抗微生物 (AMP),增强对MDR细菌的稳定性和有效性.
- 通过计算方法和模块化混合化建立一个可通用的平台,以加速AMP发现.
- 为了研究一种混合的作用机制和抗菌膜活性.
主要方法:
- 合理的设计,将片选 (AMP_scanner) 与自然片段的模块化杂交相结合.
- 从Bacillus velezensis 524B中获得的短的分类,分为离子和疏水模块.
- 将模块组装到一个新的CHCH (离子-疏水性-离子-疏水性) 脚手架上.
- 对抗菌活性,选择性指数,作用机制 (膜透,ROS生成) 和抗菌膜对MDR Acinetobacter baumannii.有效性的评估.
主要成果:
- 鉴定和优化混合CHCH_KRVL_3具有强大的活性对MDR Acinetobacter baumannii (MIC = 8 μM) 和高选择性指数 (SI > 10).
- 细菌杀菌机制的解脱,包括与酸乙醇胺 (PE) 和酸糖醇 (PG) 结合,导致膜透和活性氧物种 (ROS) 积累.
- 展示了优越的抗菌膜性能,包括消除预制生物膜和抑制PVC内管上的生物膜形成,优于聚胺B的性能.
结论:
- 开发的"自然模块+CHCH支架"平台与人工智能辅助查相结合,为加速发现新型AMP提供了强大而可通用的策略.
- CHCH_KRVL_3代表了一种有前途的化合物,用于对抗MDR细菌感染和生物膜形成.
- 这种方法克服了传统AMP的局限性,为未来对抗耐药病原体的治疗开发铺平了道路.
相关概念视频
Antimicrobial Effectiveness
1.4K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.4K
Antimicrobial Proteins
14.8K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.8K
Development of Antibiotic Resistance
1.7K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K
Biological Methods for Microbial Control
1.0K
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
1.0K
Combined Effects of Drugs: Synergism
7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.1K


